Efficacy data of
ICLUSIG (ponatinib) in Ph+ ALL
Explore ICLUSIG efficacy in Philadelphia chromosome-positive acute lymphoblastic leukemia
Explore ICLUSIG efficacy in Philadelphia chromosome-positive acute lymphoblastic leukemia
Pivotal efficacy data across two trials covering newly diagnosed Ph+ ALL and resistant/T315I-positive Ph+ ALL1-3